Skip to Main Content

Paper Details

Treatment-induced oxidative stress and cellular antioxidant capacity determine response to bortezomib in mantle cell lymphoma.
Clin Cancer Res
75
2011
-, Affymetrix microarrays, Bortezomib, H2O2, MCL, MCL cell lines, NOXA, NRF2, NRF2 gene, Purified, Purified tumor cells, RESULTS, bortezomib, bortezomib-resistant cells, bortezomib-sensitive cells, circulating tumor cells, leukemic MCL, mantle cell lymphoma, patients, primary tumor, primary tumor cells, relapsed mantle cell lymphoma, resistant cells, sensitive cells, tumor cells, tumors

Datasets

Release 1.2